Keele Research Repository

Article

Wheatley, D, Haviland, J, Patel, J, Sydenham, M, Alhasso, A, Chan, C, Cleator, S, Coles, C, Donovan, E, Kirby, A, Kirwan, C, Nabi, Z, Sawyer, E, Somaiah, N, Syndikus, I, Venables, K, Yarnold, J, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097 and Bliss, J (2022) First results of FAST-Forward phase 3 RCT nodal substudy: 3-year normal tissue effects. Radiotherapy and Oncology, 170. S75 - S76.

Hoskin, P, Popova, B, Schofield, O, Brammer, C, Robinson, M, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Madhavan, K, Illidge, T, Gallop-Evans, E, Syndikus, I, Clifton-Hadley, L and Kirkwood, AA (2021) 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. Lancet Oncology, 22 (3). pp. 332-340.

Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Haviland, JS, Wheatley, DA, Sydenham, MA, Alhasso, A, Bloomfield, D, Chan, C, Churn, M, Cleator, S, Coles, CE, Emson, M, Goodman, A, Harnett, A, Hopwood, P, Kirby, AM, Kirwan, C, Morris, C, Nabi, Z, Sawyer, E, Somaiah, N, Stones, L, Syndikus, I, Wilcox, M, Bliss, JM and Yarnold, JR (2020) FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 5-year results. Radiotherapy and Oncology, 152 (S1). S346 - S347.

Brunt, AM, Haviland, JS, Sydenham, M, Agrawal, RK, Algurafi, H, Alhasso, A, Barrett-Lee, P, Bliss, P, Bloomfield, D, Bowen, J, Donovan, E, Goodman, A, Harnett, A, Hogg, M, Kumar, S, Passant, H, Quigley, M, Sherwin, L, Stewart, A, Syndikus, I, Tremlett, J, Tsang, Y, Venables, K, Wheatley, D, Bliss, JM and Yarnold, JR (2020) Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer. Journal of Clinical Oncology, 38 (28). pp. 3261-3272.

Brunt, AM, Haviland, JS, Wheatley, DA, Sydenham, MA, Alhasso, A, Bloomfield, DJ, Chan, C, Churn, M, Cleator, S, Coles, CE, Goodman, A, Harnett, A, Hopwood, P, Kirby, AM, Kirwan, CC, Morris, C, Nabi, Z, Sawyer, E, Somaiah, N, Stones, L, Syndikus, I, Bliss, JM, Yarnold, JR and FAST-Forward Trial Management Group, . (2020) Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. The Lancet, 395 (10237). 1613 - 1626.

Hoskin, P, Kirkwood, A, Popova, B, Schofield, O, Brammer, C, Robinson, M, Brunt, M ORCID: https://orcid.org/0000-0002-4797-5097, Krishnaswamy, M, Illidge, T, Gallop-Evans, E, Syndikus, I and Clifton-Hadley, L (2019) long term follow-up of FoRT: a phase 3 multi-center prospective randomized trial of radiation therapy for follicular and marginal zone lymphoma. Hematological Oncology, 37. 219 - 220.

Coles, CE, Griffin, CL, Kirby, AM, Haviland, JS, Titley, JC, Benstead, K, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Chan, C, Ciurlionis, L, Din, OS, Donovan, EM, Eaton, DJ, Harnett, AN, Hopwood, P, Jefford, ML, Jenkins, PJ, Lee, CE, McCormack, M, Sherwin, L, Syndikus, I, Tsang, Y, Twyman, NI, Ventikaraman, R, Wickers, S, Wilcox, MH, Bliss, JM and Yarnold, JR (2019) Dose escalated simultaneous integrated boost radiotherapy for women treated by breast conservation surgery for early breast cancer: 3-year adverse effects in the IMPORT HIGH trial (CRUK/06/003). Cancer Research, 79 (4).

Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Haviland, J, Sydenham, M, Alhasso, A, Bloomfield, D, Chan, C, Churn, M, Cleator, S, Coles, C, Emson, M, Goodman, A, Griffin, C, Harnett, A, Hopwood, P, Kirby, A, Kirwan, C, Morris, C, Sawyer, E, Somaiah, N, Syndikus, I, Wilcox, M, Rada, Z, Wheatley, D, Bliss, J and Yarnold, J (2018) FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 3-year normal tissue effects. British Journal of Cancer, 119 (11). 41 - 41.

Velikova, G, Williams, LJ, Willis, S, Dixon, JM, Loncaster, J, Hatton, M, Clarke, J, Kunkler, IH, Russell, NS, Alhasso, A, Adamson, D, Algurafi, H, Allerton, R, Anandadas, C, Bahl, A, Barraclough, L, Barrett-Lee, P, Barthakur, U, Bedi, C, Beresford, M, Bishop, J, Blackman, G, Bliss, P, Bloomfield, D, Blunt, M, Branson, T, Brazil, L, Brunt, A, Chakrabarti, A, Chittalie, A, Churn, M, Clarke, J, Cleator, S, Crellin, P, Danwata, F, De-Silva-Minor, S, Dhadda, A, Eicholz, A, Fernando, I, Forrest, J, Fraser, J, Geropantas, K, Goodman, A, Grieve, R, Griffin, M, Hadaki, M, Hall, A, Hatton, M, Hicks, J, Hignett, S, Hogg, M, Jyothirmayi, R, Khan, M, Kumar, S, Lawton, P, Lee, D, Lewinski, C, Lim, C, Locke, I, Loncaster, J, Lumsden, G, Lupton, S, Magee, B, Marshall, J, Masinghe, S, McGregor, C, McLennan, M, Memtsa, P, Milanovic, D, Misra, V, Mithal, N, Mukesh, MB, Neal, A, Needleman, S, Persic, M, Quigley, M, Raj, S, Riddle, P, Ritchie, D, Roberts, F, Robson, P, Roe, H, Rolles, M, Shah, N, Sharma, R, Sherwin, E, Simmonds, P, Skailles, G, Skaria, S, Soe, W, Sripadam, R, Stevens, A, Stockdale, A, Storey, N, Storey, N, Syndikus, I, Thorp, N, Thorp, N, Upadhyay, S, Varughese, M, Walji, N, Welch, R, Wells, T, Wolstenholme, V, Wolstenholme, V, Woodings, P and Yuille, F (2018) Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial. The Lancet Oncology, 19 (11). 1516 - 1529.

Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Haviland, J, Sydenham, M, Al-hasso, A, Bloomfield, D, Chan, C, Churn, M, Cleator, S, Coles, C, Emson, M, Goodman, A, Griffin, C, Harnett, A, Hopwood, P, Kirby, A, Kirwan, C, Morris, C, Sawyer, E, Somaiah, N, Syndikus, I, Wilcox, M, Zotova, R, Wheatley, D, Bliss, J and Yarnold, J (2018) FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 3-year normal tissue effects. Radiotherapy and Oncology, 127 (S1). S311 -S312.

Coles, CE, Griffin, CL, Kirby, AM, Titley, J, Agrawal, RK, Alhasso, A, Bhattacharya, IS, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Ciurlionis, L, Chan, C, Donovan, EM, Emson, MA, Harnett, AN, Haviland, JS, Hopwood, P, Jefford, ML, Kaggwa, R, Sawyer, EJ, Syndikus, I, Tsang, YM, Wheatley, DA, Wilcox, M, Yarnold, JR, Bliss, JM and Trialists, IMPORT (2017) Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet, 390 (10099). 1048 - 1060.

Conference or Workshop Item

Coles, C, Haviland, JS, Kirby, AM, Bhattacharya, I, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Chan, C, Donovan, EM, Eaton, DJ, Griffin, CL, Hopwood, P, Jefford, ML, Lightowlers, S, Rajapakse, C, Sawyer, E, Stones, L, Syndikus, I, Titley, JC, Tsang, Y, Twyman, NI, Bliss, JM and Yarnold, JR (2021) IMPORT HIGH trial: Dose escalated simultaneous integrated boost radiotherapy in early breast cancer. In: ESTRO 2021, 28-31 August 2021, Madrid, Spain & Online.